Journal of Clinical Toxicology
Open Access

Kirsten Vistisen

Publications

• Case Report
  Cardiotoxicity in Asymptomatic Patients Receiving Adjuvant 5-fluorouracil
  Author(s): Karin Nielsen, Anne Polk, Dorte L Nielsen, Kirsten Vistisen and Merete Vaage-NilsenKarin Nielsen, Anne Polk, Dorte L Nielsen, Kirsten Vistisen and Merete Vaage-Nilsen
  
  Evolving evidence of cardiotoxicity in cancer patients treated with 5-fluorouracil (5-FU) has been reported. We report two different clinical manifestations of asymptomatic 5-FU-associated cardiotoxicity in patients operated for colorectal cancer and treated with adjuvant chemotherapy of 5-FU (bolus-injection and continuous infusion for 46 hours), folinic acid and oxaliplatin (FOLFOX). For a research study evaluating cardiac events during 5-FU treatment, Holter monitoring, electrocardiogram (ECG) and echocardiography were done and cardiac markers monitored before and during the first treatment course. Case report 1 presents a 75-year old woman with a medical history of paroxysmal atrial fibrillation, hypertension and hyperlipidemia. Holter monitoring revealed increasing paroxysms of atrial fibrillation, increased ventricular ectopic activity and episodes of sinoatrial arrest during in.. View More»
  DOI: 10.4172/2161-0495.1000211

  Abstract PDF

Relevant Topics